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Abstract
We describe a fatal case of Reye’s syndrome in a 12-year-old
male patient during an inﬂuenza A (H3N2) infection for which
he received salicylates. In the current situation of the novel
A/H1N1 virus pandemic, we believe that it is of high importance
to emphasize the risks associated with salicylate intake to avoid
the reappearance of Reye’s syndrome.
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Reye’s syndrome (RS) is a rare but severe and high-fatality-
rate paediatric disease, characterized by an acute encepha-
lopathy and pronounced cerebral oedema associated with
liver disease with diffuse fatty inﬁltration [1]. The CDC case
deﬁnition is: (i) acute non-inﬂammatory encephalopathy
documented clinically by an alteration in consciousness and,
if available, a record of cerebrospinal ﬂuid containing eight
leukocytes or fewer per mm3, or by a histological specimen
demonstrating cerebral oedema without perivascular or
meningeal inﬂammation; (ii) hepatopathy documented by
either a liver biopsy or autopsy considered to be diagnostic
of RS, or a three-fold or greater rise in the levels of either
serum glutamate oxaloacetate transaminase, serum glutamic
pyruvate kinase or serum ammonia; and (iii) no other rea-
sonable explanation for the cerebral or hepatic abnormalities
[2]. RS may occur at any age in childhood, although the fre-
quency is higher in childen under the age of 2 years [3]. The
illness is typically biphasic with an apparent near recovery
from a viral prodromal illness followed after a few days by
vomiting and altered consciousness. Although the mechanism
leading to RS remains unknown, it is often preceded by an
acute viral infection, usually varicella, gastroenteritis or respi-
ratory tract infection as a result of inﬂuenza virus [4]. Vari-
ous factors (viral, toxic, drug-related and metabolic) were
considered in the pathogenesis of RS, although only aspirin
intake during the prodromal phase was statistically proven to
be associated with RS [5–8]. Accordingly, warnings against
aspirin administration to children were issued in the USA in
1980, and the incidence was reduced [9]. In Reye-like syn-
drome, and as a result of inborn errors of metabolism, hypo-
glycaemia, hypoketonaemia, elevated ammonia and organic
aciduria are often evident. It is well known that fatty acid
oxidation defects can manifest as Reye-like syndrome [10]. If
the general population is not sensitized to this risk, RS may
increase in the peculiar A/H1N1 pandemic situation. We
report a fatal case of RS in a 12-year-old child who received
aspirin during an inﬂuenza infection.
In February 2009, a 12-year-old boy was admitted to the
hospital for neurological distress and gastro intestinal disease.
For 4 days, he had been suffering from a viral syndrome,
with fever (39C) and nasal discharge, which was treated by
self-administration of 250 mg of aspirin. Two days before
hospital admission, he was no lonfer febrile but suffered from
vomiting and complete digestive intolerance. The next day,
he presented with haematemesis, which motivated admission
to the emergency ward. Upon admission, his temperature
was 35.8C, his pulse was 110 per minute, and blood pres-
sure was 128/73 mmHg. Laboratory analyses revealed major
abnormalities, with hypoglycaemia (0.4 mM), acute hepatocel-
lular deﬁciency with a prothrombin index < 10% (V factor
0.04), aspartate and alanine aminotransferase levels at
20 130 IU/L and 10 690 IU/L, respectively, and hyperammo-
naemia (255 lM). He was transferred into the paediatric
intensive care unit, where a nasopharyngeal aspirate was
collected and sent to the microbiology laboratory. Shortly
after transfer, he presented alternative episodes of agitation,
confusion and drowsiness, which were diagnosed as a hepatic
ª2010 European Society of Clinical Microbiology and Infectious Diseases
No claim to original US government works
RESEARCH NOTES VIROLOGY
encephalopathy stage II–III. There was no measured intracra-
nial hypertension. Biochemistry parameters showed hypona-
traemia (127 mM), hyperkaliaemia (6.8 mM), lactic acidosis
(5 mM) and renal deﬁciency, with a plasma urea level of
8.9 mM and a plasma creatinine level of 227 lM, which
required dialysis. Treatment with suitable glycaemic correc-
tion and fast recharge in sodium was administered. A few
hours later, the patient developed a moderate polypnea,
which required mechanical ventilation. He had episodes of
bradycardia and tachycardia with ventricular premature com-
plexes. During the ﬁrst 12 h after hospitalization, he pre-
sented a progressive deterioration of consciousness despite
a suitable correction of glycaemia and serum sodium levels.
In the early evening, neurovegetative disturbances appeared
with mydriasis, which were initially reversible with osmother-
apie and neuroanesthesia, and then irreversible 12 h after
admission. A cranial Doppler examination demonstrated evi-
dence of massive cerebral oedema. He died 2 days after
admission.
Evidence for infection with A/H3N2 inﬂuenza virus was
demonstrated via: (i) antigen detection by rapid inﬂuenza
detection tests using immunochromatographic technology
(Directigen EZ Flu A+B; Becton-Dickinson Biosciences,
Franklin Lakes, NJ, USA); (ii) virus detection using a direct
immunoﬂuorescence test in the combined kit (anti-Adenovi-
rus + Inﬂuenza A, B + Parainﬂuenza 1, 2, 3 + RSV; Argene,
Verniolle, France); (iii) PCR detection by qualitative real-time
RT-PCR [11]; (iv) subtyping by sequencing [12]; and (v) virus
isolation onto Madin–Darby canine kidney cells.
Two liver biopsies were formalin-ﬁxed and parafﬁn
embedded. Serial sections were performed, with immunohis-
tochemistry including anti-Ki 67 and anti-active caspase 3,
antibodies, to assess cell proliferation and cell apoptosis,
respectively (Fig. 1). Pathological lesions were diffuse and
similar for the two biopsies (thirty portal tracts). Moderate
mononuclear and polymorphonuclear inﬁltrates were present
within the portal tracts but without destruction of the limit-
ing plate and bile ducts. Major alterations were located
within the hepatic lobules (zones 1, 2 and 3). Hepatocytes
exhibited severe mixed micro-macrovacuolar steatosis asso-
ciated with numerous lytic necrosis areas and apoptotic
bodies. The proliferation index evaluated with anti-Ki67 anti-
body was low (i.e. 5–10% of hepatocytes). Anti-active cas-
pase 3 was positive on up to 50% of hepatocytes, highlighting
a massive apoptotic process. In muscle, enzymatic spectro-
photometry measurements of the individual respiratory chain
complexes revealed no decrease of complex I–V activity. A
screen for mitochondrial DNA deletion and common muta-
tions (m.3243A>G, m.8344A<G, m.8993T<G) was negative.
Mitochondrial DNA quantiﬁcation, performed by quantitative
RT-PCR, showed no depletion (152% of age-matched con-
trols). Moreover, manifestations of Reye-like syndrome usu-
ally occur before the age of 3 years [13].
The pathological ﬁndings were highly compatible with a RS
in a patient who presented with a laboratory-conﬁrmed
acute H3N2 inﬂuenza A virus infection treated with aspirin.
In addition, all CDC deﬁnition criteria of RS were fulﬁlled
[2]. A low cerebrospinal ﬂuid leukocyte count was not dem-
onstrated because a cerebrospinal ﬂuid tap test was not per-
formed. Furthermore, additional criteria that may help to
conﬁrm the diagnosis were present in our case: age
<15 years, hypoglycaemia, vomiting, peripheral zonal hepatic
necrosis, lack of jaundice, metabolic acidosis and elevated
prothrombin time. Clinical, pathological, virological and bio-
chemical ﬁndings, together with the epidemiological context,
unambiguously demonstrate that our patient presented with
a RS from which he died. Written authorization has been
obtained from the parents of the patient.
This recent case highlights that the prescription of aspirine
or aspirin-containing medication to patients presenting with
fever in the context of febrile illness compatible with viral
infection such as inﬂuenza virus infection must be proscribed.
In the early 1980s in the USA, warnings to physicians were
associated with a clear decrease of RS [14]. A similar ten-
dency was observed in the UK, with incidences varying from
0.3 per 100 000 in 1985–86 to 0.1 per 100 000 in 1990–91
[15,16]. No comparative data were available in France; how-
ever, in 1995–1996, the RS incidence was 0.08 per 100 000,
in the same range as those in the USA and the UK [17].
We believe that the same warnings should be reiterated in
(a) (b)
FIG. 1 Pathological ﬁndings in liver
biopsy. (a) Liver biopsy showing lobular
steatosis with extensive hepatic apopto-
sis (hydroxyethyl starch, ·100). (b)
Immunohistochemistry: periportal hepa-
tic staining with an anti-active caspase 3
antibody (· 250).
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European countries to avoid an increase in the incidence of
RS in the current context of the novel A/H1N1 inﬂuenza
virus pandemic. Because self-administration of aspirin or aspi-
rin-containing medications is frequent speciﬁcally during the
winter season, it is of utmost importance to disseminate
messages to the public concerning the possible dramatic
consequences of aspirin intake during viral infections.
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Abstract
By screening faecal samples collected over four consecutive
years (2002–2005) from hospitalized children with diarrhoea in
Palermo, Italy, astroviruses (HAstVs) were detected in 3.95% of
the patients. The predominant type circulating was HAstV-1 but,
in 2002, only HAstV-2 and -4 were identiﬁed. Interestingly, the
HAstVs-2 detected appeared to be consistently different in 5¢
end of their open reading frame 2 from the previously described
subtypes. These novel type 2 strains were included in a new 2c
lineage based on the phylogenetic analysis and the presence of
nine peculiar substitutions.
Keywords: Astrovirus, gastroenteritis, genotyping, Italy,
sequence analysis
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Human astroviruses (HAstVs) are enteric viruses associated
with gastroenteritis in young children in both developed and
developing countries [1]. Their prevalence is usually in the
range 2–9%, although some studies in developing countries
report rates of up to 28.2% [1–5]. The pathogenic role of
HAstVs is still disputed because they are frequently found
(33–65% of the cases) in conjunction with other enteric
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